Publications by authors named "Jesper Grarup"

Claim this Profile
L
Lolland-Falster Health Study: Study protocol for a household-based prospective cohort study.
Randi Jepsen, Cecilie Lindström Egholm, John Brodersen, Erik Simonsen, Jesper Grarup

Scand J Public Health· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients.
Jens-Ulrik Stæhr Jensen, Lars Peters, Theis S Itenov, Morten Bestle, Katrin M Thormar, Jesper Grarup

Clin Chem Lab Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir-Ritonavir Plus Either Raltegravir or Tenofovir-Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial.
Alan Winston, Wolfgang Stöhr, Andrea Antinori, Helene Amieva, Philippe Perré, Jesper Grarup

J Acquir Immune Defic Syndr· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial.
Jens-Ulrik S Jensen, Theis S Itenov, Katrin M Thormar, Lars Hein, Thomas T Mohr, Jesper Grarup

Ann Intensive Care· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials.
Gregg S Larson, Cate Carey, Jesper Grarup, Fleur Hudson, Karen Sachi

Clin Trials· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143.
Juan Berenguer, Ferdinand Wit, Per O Jansson, Christine Schwimmer, Justyna D Kowalska, Jesper Grarup

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime.
Jens-Ulrik S Jensen, Lars Hein, Bettina Lundgren, Morten H Bestle, Thomas Mohr, Jesper Grarup

Crit Care Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INVESTIGATING THE EFFICACY OF CLINICAL TRIAL MONITORING STRATEGIES: Design and Implementation of the Cluster Randomized START Monitoring Substudy.
Katherine Huppler Hullsiek, Jonathan M Kagan, Nicole Engen, Jesper Grarup, Fleur Hudson

Ther Innov Regul Sci· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults.
Catia Marzolini, Caroline Sabin, François Raffi, Marco Siccardi, Cristina Mussini, Jesper Grarup

AIDS· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
François Raffi, Abdel G Babiker, Laura Richert, Jean-Michel Molina, Elizabeth C George, Jesper Grarup

Lancet· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
Frederik N Engsig, Robert Zangerle, Olga Katsarou, Francois Dabis, Peter Reiss, Jesper Grarup

Clin Infect Dis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, Antonella d'Arminio Monforte, Norbert Brockmeyer, Jesper Grarup

PLoS Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.

J Infect Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial.
Jens-Ulrik Stæhr Jensen, Lars Hein, Bettina Lundgren, Morten Heiberg Bestle, Thomas Mohr, Jesper Grarup

BMJ Open· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.

PLoS Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

Int J Epidemiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.

J Acquir Immune Defic Syndr· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.

Lancet Infect Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
Jens U Jensen, Lars Hein, Bettina Lundgren, Morten H Bestle, Thomas T Mohr, Jesper Grarup

Crit Care Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of triple-class virological failure in children with HIV: a retrospective cohort study.

Lancet· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.
James D Neaton, Abdel Babiker, Mark Bohnhorst, Janet Darbyshire, Eileen Denning, Jesper Grarup

Clin Trials· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.
Jens-Ulrik Jensen, Bettina Lundgren, Lars Hein, Thomas Mohr, Pernille L Petersen, Jesper Grarup

BMC Infect Dis· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis